Healthcare Sales & Marketing Network News: allogeneic

Searching News Database: allogeneic

HSMN NewsFeed - 6 May 2026
Cytora Ltd. Appoints Dr. Thomas Serena, MD, World Renowned Wound Care Expert to Scientific Advisory Board to Lead Patient Treatment Access and Data Collection for CytoraStem(TM) human Oral Mucosa Stem Cell (hOMSC) Therapy
Regenerative Medicine Wound Care Personnel

HSMN NewsFeed - 26 Feb 2026
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 20 Feb 2026
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 19 Jan 2026
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene's NouvNeu001, Making It the World's First iPSC Therapy with Both FTD and RMAT Recognitions
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 27 May 2025
BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn(R) Phase 3b ALS Clinical Trials
Regenerative Medicine Neurology

HSMN NewsFeed - 19 May 2025
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn(R) for ALS
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 30 Jan 2025
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Dec 2024
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Nov 2024
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Oct 2024
AvenCell Raises $112 Million in Series B; Funding Led by Novo Holdings
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Oct 2024
Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Aug 2024
Haemonetics Announces Full Market Release for VASCADE MVP(R) XL Vascular Closure System
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 25 Mar 2024
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Mar 2024
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 19 Jan 2024
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Progressive Multiple Sclerosis
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 13 Dec 2023
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Myasthenia Gravis
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Nov 2023
Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune(R) Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization
Biopharmaceuticals Product Recall

HSMN NewsFeed - 1 Nov 2023
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 8 Sep 2023
Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR(TM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Aug 2023
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Jun 2023
Acepodia Secures $100 Million Series D Financing to Advance
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 28 Feb 2023
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Aug 2022
Verismo Therapeutics Announces Submission of IND Application to the FDA for SynKIR-110TM, a KIR-CAR T-cell Immunotherapy Candidate
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 10 Aug 2022
GentiBio Announces Collaboration with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for Inflammatory Bowel Diseases
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 19 Jul 2022
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 May 2022
MindMed Appoints Schond L. Greenway as Chief Financial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 17 Mar 2022
TC BioPharm Announces FDA Orphan Drug Status Granted for OmnImmune(R)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 22 Feb 2022
TC Biopharm Announces Appointment of New Board Members
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Feb 2022
GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jan 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Nov 2021
Priothera Appoints Elisabeth Kueenburg M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Oct 2021
BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Oct 2021
Poseida Therapeutics Announces Leadership Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2021
XNK Therapeutics appoints Markus Thor as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Aug 2021
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-BCMA-ALLO1, an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Aug 2021
GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics with Potential to Restore Immune Tolerance and Durably Treat Autoinflammation
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 May 2021
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Regenerative Medicine Licensing

HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 23 Mar 2021
Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Feb 2021
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
Regenerative Medicine Orthopaedic FDA

HSMN NewsFeed - 12 Feb 2021
Mallinckrodt Provides Regulatory Update on StrataGraft(R)
Devices Dermatology FDA

HSMN NewsFeed - 12 Feb 2021
The Lancet Publishes Libtayo(R) (cemiplimab) Data Showing Extended Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50%
Biopharmaceuticals Oncology

HSMN NewsFeed - 10 Feb 2021
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 18 Jan 2021
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 22 Dec 2020
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Nov 2020
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Nov 2020
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 7 Oct 2020
Citius Pharmaceuticals Signs an Exclusive Worldwide Licensing Agreement with Novellus Therapeutics for Unique iMSC-Therapy for Acute Inflammatory Respiratory Conditions including COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 25 Aug 2020
DiscGenics Raises $50 Million in Series C Funding
Regenerative Medicine Orthopaedic Venture Capital

HSMN NewsFeed - 21 Aug 2020
Cipla and Stempeutics collaborate for launch of Stempeucel(R), first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 26 Jun 2020
Citius Receives FDA Response on Pre-Investigational New Drug (PIND) Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jun 2020
Poseida Therapeutics Raises $110 Million in Series D Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 23 Jun 2020
Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 Jun 2020
FDA Clears IND for iNKT Cells to Treat COVID-19 Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 7 May 2020
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
Biopharmaceuticals Licensing

HSMN NewsFeed - 24 Mar 2020
MaxCyte and Allogene Therapeutics Sign Clinical and Commercial License Agreement to Enable the Advancement of Allogeneic CAR T (AlloCAR T(TM)) Therapies
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 22 Jan 2020
Celularity Announces FDA Clearance of Landmark IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 12 Dec 2019
Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 1 Nov 2019
CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom
Devices

HSMN NewsFeed - 8 Aug 2019
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 7 Aug 2019
Camber Spine Announces Addition of Biologics to Its Portfolio
Devices Orthopaedic Product Launch Distribution

HSMN NewsFeed - 1 Aug 2019
Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo(R) (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Jul 2019
Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 30 May 2019
Calidi Biotherapeutics Announces The Appointment Of Seasoned Biotech Executive Dr. Ashok Srivastava To Their Scientific Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 Mar 2019
Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Mar 2019
Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome
Biopharmaceuticals

HSMN NewsFeed - 16 Jan 2019
Terumo Introduces Its Smallest, Lowest Prime Volume, Full-Size Adult* Capiox(R) Oxygenator
Devices Surgery Product Launch

HSMN NewsFeed - 8 Jan 2019
Cellenkos, Inc. Appoints Elizabeth Read as Chief Technology Officer, Adding Technology and Regulatory Affairs Expertise to its Executive Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2018
NOVADIP BIOSCIENCES Appoints Jeff Abbey as CEO
Regenerative Medicine Personnel

HSMN NewsFeed - 29 Nov 2018
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
Regenerative Medicine Endocrinology Venture Capital

HSMN NewsFeed - 14 Nov 2018
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 29 Aug 2018
Longeveron Appoints Arin Maercks Chief Commercial Officer
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 29 Aug 2018
European Commission Approves BLINCYTO(R) (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Jul 2018
Sangamo Therapeutics to Acquire TxCell
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 27 Jun 2018
Adicet Bio appoints Stewart Abbot, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Jun 2018
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine(R) (sargramostim) for the Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Apr 2018
Adicet Bio appoints Elizabeth "EJ" Read, M.D. as Chief Technology Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Apr 2018
Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes
Biopharmaceuticals Endocrinology Licensing

HSMN NewsFeed - 21 Mar 2018
TCR2 Therapeutics Raises $125 Million in Oversubscribed Series B Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 22 Feb 2018
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 1 Feb 2018
Partner Therapeutics (PTx) Acquires Leukine(R) from Sanofi
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 22 Jan 2018
Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2017
Mylan and Aspen Announce Launch of Generic Busulfex(R) Injection
Biopharmaceuticals Oncology Generics Product Launch

HSMN NewsFeed - 29 Nov 2017
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Nov 2017
Pique Therapeutics Announces Positive Results in Phase 2 Clinical Trial of Lead Immunotherapy for Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Oct 2017
NuVasive Receives Expanded FDA 510(k) Clearance For TLX Interbody System Used In TLIF Procedures
Devices Neurosurgery Orthopaedic FDA

HSMN NewsFeed - 4 Oct 2017
Capricor Therapeutics Presents Positive Six-Month Results in Duchenne Muscular Dystrophy at World Muscle Society International Congress
Regenerative Medicine

HSMN NewsFeed - 3 Oct 2017
DiscGenics Receives FDA Allowance of IND to Commence Clinical Study of Its Degenerative Disc Disease Therapy
Devices Regenerative Medicine Orthopaedic FDA

HSMN NewsFeed - 26 Sep 2017
DiscGenics Raises $14 Million in Series B Financing
Regenerative Medicine Orthopaedic Venture Capital

HSMN NewsFeed - 18 Jul 2017
Capricor Receives Rare Pediatric Disease Designation from FDA for CAP-1002 for Patients with Duchenne Muscular Dystrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jul 2017
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
Regenerative Medicine Neurology

HSMN NewsFeed - 28 Jun 2017
Adicet Bio Appoints Jesse McGreivy, M.D., Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 May 2017
Capricor Therapeutics Provides Update on ALLSTAR Trial
Regenerative Medicine Cardiology

HSMN NewsFeed - 11 May 2017
New MRI Data from Asterias' Ongoing SCiStar Clinical Study Indicates AST-OPC1 Cells Prevent Formation of Damaging Lesion Cavities in Patients Suffering Severe Spinal Cord Injury
Regenerative Medicine Neurosurgery

HSMN NewsFeed - 26 Apr 2017
Asterias Announces Publication of Positive Phase 2 Data on AST-VAC1 for the Treatment of Acute Myeloid Leukemia (AML) in 'Cancer'
Biopharmaceuticals Regenerative Medicine Oncology

HSMN NewsFeed - 3 Apr 2017
Atara Bio Expands Management Team, Appoints Joe Newell as Executive Vice President, Chief Technical Operations Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Mar 2017
FDA Approves Merck’s KEYTRUDA(R) (pembrolizumab) for Adult and Pediatric Patients with Classical Hodgkin Lymphoma (cHL) Refractory to Treatment, or Who Have Relapsed After Three or More Prior Lines of Therapy
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Mar 2017
Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 Mar 2017
BLINCYTO(R) (blinatumomab) Significantly Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Compared To Chemotherapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Feb 2017
Capricor Therapeutics Provides Update on Natriuretic Peptide Program
Biopharmaceuticals

HSMN NewsFeed - 20 Jan 2017
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Dec 2016
Zimmer Biomet Strengthens Spine Offering with PrimaGen Advanced(TM) Allograft
Devices Orthopaedic Product Launch

HSMN NewsFeed - 11 Nov 2016
Bristol-Myers Squibb’s Opdivo(R) (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Oct 2016
Bristol-Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) for the Treatment of Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant and Treatment With Brentuximab Vedotin
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Sep 2016
Biologica Technologies(R) launches Allofill(TM) injectable adipose filler at the annual gathering for the American Society of Plastic Surgeons (ASPS)
Devices Dermatology Product Launch

HSMN NewsFeed - 23 Sep 2016
BioLineRx Announces In-licensing of Novel Treatment for Liver Failure Conditions Under Strategic Collaboration
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Aug 2016
BioLineRx Names Philip A. Serlin as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jul 2016
Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 29 Jun 2016
AbbVie Announces Fourth Breakthrough Therapy Designation Granted by the U.S. Food and Drug Administration (FDA) for Ibrutinib (IMBRUVICA(R)) for Chronic Graft-Versus-Host-Disease (cGVHD), a Rare Condition with Limited Treatment Options
Biopharmaceuticals

HSMN NewsFeed - 29 Feb 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 28 Dec 2015
Chimerix Announces Top-Line Results From Phase 3 SUPPRESS Trial of Brincidofovir
Biopharmaceuticals

HSMN NewsFeed - 24 Nov 2015
European Commission Approves Amgen's BLINCYTO(R) (blinatumomab) for the Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 17 Jun 2015
Centinel Spine(TM) Receives Allogeneic Bone Graft Indication For Its Anterior Lumbar Product Family
Devices FDA Neurosurgery Orthopaedic

HSMN NewsFeed - 29 Dec 2014
BioTime Appoints Adi Mohanty Chief Operating Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
Regenerative Medicine HIV/AIDS

HSMN NewsFeed - 26 Sep 2014
Sumitomo Dainippon Pharma and SanBio Conclude Joint Development and License Agreement for North America over SB623, Therapy for Stroke
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 9 Jun 2014
Batu Biologics Announces FDA Development Plans for ValloVax(TM) Angiogenesis-Targeting Cancer Vaccine
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 May 2014
Veloxis Receives Positive Opinion from CHMP for Envarsus(R) for Treatment of Both Kidney and Liver Transplant Patients
Biopharmaceuticals Regulatory

HSMN NewsFeed - 12 Mar 2014
RTI Surgical(TM) Launches Two Natural Bone Grafting Solutions at AAOS Annual Meeting
Devices Orthopaedic Product Launch

HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2013
RTI Surgical(TM) Announces First Implantation of map3(TM) Cellular Allogeneic Bone Graft in a Foot and Ankle Procedure
Devices Orthopaedic

HSMN NewsFeed - 8 Jul 2013
Capricor and Nile Therapeutics Announce Merger Agreement
Regenerative Medicine Cardiology Mergers & Acquisitions

HSMN NewsFeed - 12 Jun 2013
RTI Biologics(R) Announces Agreement to Acquire Pioneer(R) Surgical Technology
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 12 Mar 2013
TiGenix to Obtain National Reimbursement in Spain for Its Innovative Cartilage Therapy ChondroCelect(R)
Regenerative Medicine Orthopaedic Reimbursement

HSMN NewsFeed - 7 Mar 2013
Capricor, Inc. Appoints Anthony Davies, Ph.D., Chief Technology Officer
Regenerative Medicine Cardiology Personnel

HSMN NewsFeed - 14 Jan 2013
SanBio Announces Enrollment Of The Second Cohort Of Patients In Its Clinical Trial Of Stem Cell Therapy For Chronic Stroke
Regenerative Medicine Neurology

HSMN NewsFeed - 3 Jan 2013
NewLink Genetics Appoints Mr. Brian Wiley as Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Nov 2012
Smith & Nephew Announces Agreement To Acquire Assets Of Healthpoint Biotherapeutics
Biopharmaceuticals Wound Care Orthopaedic Acquisitions

HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 15 Oct 2012
AiCuris and Merck Enter Exclusive Worldwide License Agreement for Investigational Portfolio Targeting Human Cytomegalovirus
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Sep 2012
Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
Regenerative Medicine Oncology

HSMN NewsFeed - 9 Jul 2012
Capricor Announces FDA Approval To Initiate ALLSTAR Trial of Allogeneic Stem Cell Therapy In Patients Following Heart Attack
Regenerative Medicine Cardiology FDA

HSMN NewsFeed - 27 Jun 2012
PRIMA Study Shows Treatment with Privigen(R) Improved Function in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals

HSMN NewsFeed - 2 Apr 2012
AlloCure Raises $25 Million Series B Venture Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Mar 2012
SanBio Announces Enrollment of First Cohort of Patients in Its Clinical Trial of Stem Cell Therapy for Chronic Stroke
Regenerative Medicine Neurology

HSMN NewsFeed - 15 Mar 2012
CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
Biopharmaceuticals Surgery

HSMN NewsFeed - 12 Mar 2012
Organogenesis Inc. Announces FDA Approval of GINTUIT(TM) for Oral Soft Tissue Regeneration
Regenerative Medicine Wound Care FDA

HSMN NewsFeed - 8 Mar 2012
Bellicum Closes $20 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Feb 2012
The Lancet Publishes Results from Gentium's Phase III Defibrotide Trial for the Prevention of VOD in Paediatric Patients
Biopharmaceuticals

HSMN NewsFeed - 3 Nov 2011
Pluristem Announces Positive 12-Month Data From the Use of PLX-PAD for the Treatment of Critical Limb Ischemia
Regenerative Medicine

HSMN NewsFeed - 11 Oct 2011
Aduro BioTech Announces First Patient Treated in Phase 2 Pancreatic Cancer Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Aug 2011
NexBio's DAS181 (Fludase(R)*) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis
Biopharmaceuticals

HSMN NewsFeed - 26 Aug 2011
Medistem Submits Response to FDA Clinical Hold
Regenerative Medicine FDA

HSMN NewsFeed - 15 Mar 2011
Incyte’s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Feb 2011
Stemedica Receives Approval From UCSD to Initiate Ischemic Stroke Study With Adult Allogeneic Stem Cells
Biopharmaceuticals Regenerative Medicine Neurology

HSMN NewsFeed - 8 Feb 2011
Pervasis Receives FDA Fast Track Status for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Biopharmaceuticals Interventional FDA

HSMN NewsFeed - 20 Sep 2010
Athersys Announces Groundbreaking Data Showing Neuroprotective Effects of MultiStem Therapy for Traumatic Brain Injury
Regenerative Medicine Neurology

HSMN NewsFeed - 9 Aug 2010
CryoLife Receives FDA 510(k) Clearance for CryoPatch(R) SG Pulmonary Human Cardiac Patch Shelf-life Extension
Devices Cardiology Surgery FDA

HSMN NewsFeed - 6 Jul 2010
AlloCure Names Robert M. Brenner, M.D. Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 8 Jun 2010
Bioartificial Human Liver Therapy Trial Progressing
Devices

HSMN NewsFeed - 8 Jun 2010
CryoLife Receives FDA 510(k) Clearance for CryoValve(R) SG Pulmonary Heart Valve Shelf-life Extension
Devices Cardiology FDA

HSMN NewsFeed - 26 May 2010
Organogenesis Announces Symposium for the Treatment of Chronic Wounds at EWMA Annual Conference in Switzerland
Regenerative Medicine Wound Care

HSMN NewsFeed - 19 Mar 2010
Stemedica Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic Mesenchymal Stem Cells
Regenerative Medicine Neurology

HSMN NewsFeed - 10 Feb 2010
Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
Regenerative Medicine Oncology

HSMN NewsFeed - 1 Feb 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Dec 2009
Hana Biosciences Announces Positive Data From Pivotal rALLy Clinical Trial of Marqibo(R) in Acute Lymphoblastic Leukemia at 51st American Society of Hematology Annual Meeting
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 6 Oct 2009
CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves
Devices Cardiology FDA

HSMN NewsFeed - 23 Sep 2009
Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine

HSMN NewsFeed - 16 Sep 2009
Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 10 Sep 2009
Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine

HSMN NewsFeed - 8 Sep 2009
Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
Biopharmaceuticals

HSMN NewsFeed - 21 Aug 2009
Stemedica Requests Pre-IND Meeting With FDA
Regenerative Medicine Neurology FDA

HSMN NewsFeed - 19 Aug 2009
Gentium Reports Top Line Results from the Phase III Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
Biopharmaceuticals

HSMN NewsFeed - 18 Aug 2009
CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material
Devices Cardiology

HSMN NewsFeed - 4 Aug 2009
DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Jun 2009
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
Biopharmaceuticals

HSMN NewsFeed - 16 Jun 2009
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
Regenerative Medicine

HSMN NewsFeed - 28 May 2009
Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients
Biopharmaceuticals FDA

HSMN NewsFeed - 5 May 2009
Pervasis Therapeutics Granted Orphan Drug Designation for Vascugel
Biopharmaceuticals Regenerative Medicine FDA

HSMN NewsFeed - 17 Feb 2009
FDA Clears New Immune Response Claim for the CryoValve(R) SG Pulmonary Human Heart Valve
Devices Cardiology FDA

HSMN NewsFeed - 12 Feb 2009
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
Regenerative Medicine Cardiology

HSMN NewsFeed - 9 Feb 2009
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
Biopharmaceuticals

HSMN NewsFeed - 23 Jan 2009
Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
Regenerative Medicine Neurosurgery FDA

HSMN NewsFeed - 15 Dec 2008
FDA Approves Genzyme's Mozobil
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Dec 2008
NovaRx Appoints Industry Veteran as President and COO
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Oct 2008
Pervasis Therapeutics Appoints Life Sciences Industry Executive Frederic Chereau as Company's President and Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 17 Sep 2008
DOR BioPharma Forms orBec(R) European Medical Advisory Board
Biopharmaceuticals

HSMN NewsFeed - 5 Aug 2008
Pervasis Therapeutics Appoints Frank Litvack, M.D., Former CEO of Conor Medsystems, to its Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 4 Aug 2008
Pluristem Appoints Ms. Chaya Mazouz Clinical Operations Director
Regenerative Medicine Personnel

HSMN NewsFeed - 22 Jul 2008
Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 May 2008
Bayer Announces Availability of Reformulated Liquid Leukine(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 14 May 2008
Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin
Devices Monitoring FDA

HSMN NewsFeed - 7 May 2008
Astellas' Mycamine(R) (micafungin) Licensed for Use in Europe to Treat Serious Fungal Infections
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 May 2008
REGiMMUNE Raises $8,000,000 in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Apr 2008
Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Mar 2008
CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
Devices Cardiology

HSMN NewsFeed - 4 Mar 2008
Pluristem Submits Pre-IND Application in Germany to Initiate Clinical Trials of PLX-PAD for Peripheral Artery Disease
Regenerative Medicine Regulatory

HSMN NewsFeed - 7 Feb 2008
CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
Devices FDA Cardiology

HSMN NewsFeed - 15 Jan 2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing
Regenerative Medicine Venture Capital

HSMN NewsFeed - 9 Jan 2008
Ortec Shareholders Approve Corporate Name Change to Forticell Bioscience, Inc.
Regenerative Medicine Wound Care

HSMN NewsFeed - 8 Jan 2008
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Regenerative Medicine

HSMN NewsFeed - 3 Jan 2008
DOR BioPharma Receives Orphan Drug Designation for Oral BDP for the Treatment of Pediatric Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 20 Dec 2007
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
Regenerative Medicine Cardiology

HSMN NewsFeed - 17 Dec 2007
Otsuka Pharmaceutical Acquires Rights to IV Busulfex From PDL BioPharma
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 7 Dec 2007
DOR BioPharma Announces Results of orBec(R) End of Review Conference With the FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Nov 2007
ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 Oct 2007
NCCN Updates Multiple Myeloma Guidelines
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Oct 2007
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
Biopharmaceuticals

HSMN NewsFeed - 27 Sep 2007
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Sep 2007
Aranesp(R) DAHANCA 10 Study Results Presented at ECCO Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Sep 2007
Ortho Biotech Supports FDA Advisory Committees' Recommendations on Use of ESAs in Chronic Renal Failure Patients
Biopharmaceuticals

HSMN NewsFeed - 11 Sep 2007
Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
Biopharmaceuticals

HSMN NewsFeed - 11 Sep 2007
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
Biopharmaceuticals

HSMN NewsFeed - 6 Sep 2007
Aranesp(R) Study Showing No Negative Impact on Survival in SCLC Presented at World Conference on Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Sep 2007
Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
Biopharmaceuticals

HSMN NewsFeed - 11 Jul 2007
Ortec International: Dr. Costa Papastephanou Appointed CEO
Regenerative Medicine Wound Care Personnel

HSMN NewsFeed - 11 Jul 2007
StemCyte Appoints Robert Dickey IV as Senior Vice President and Chief Financial Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 5 Jul 2007
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
Biopharmaceuticals

HSMN NewsFeed - 20 Jun 2007
Baxter Signs Agreements to Evaluate TISSEEL Use With New, Innovative Therapies
Devices Regenerative Medicine

HSMN NewsFeed - 9 May 2007
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
Biopharmaceuticals FDA

HSMN NewsFeed - 2 May 2007
FDA Clearance Received for Heart Attack Stem Cell Clinical Trial
Regenerative Medicine Cardiology FDA

HSMN NewsFeed - 30 Apr 2007
NCCN Updates Prevention and Treatment of Cancer-Related Infections Guidelines
Oncology

HSMN NewsFeed - 19 Apr 2007
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Mar 2007
New Cancer Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Mar 2007
DOR BioPharma Forms orBec(R) Medical Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Mar 2007
Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel(TM)
Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 9 Mar 2007
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 9 Mar 2007
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 Feb 2007
Ortec Initiates Premarket Approval (PMA) Application Filing Seeking Approval for OrCel(R) in Treating Venous Leg Ulcers
Regenerative Medicine Wound Care FDA

HSMN NewsFeed - 14 Feb 2007
Pluristem Announces Private Equity Investment of $8M
Regenerative Medicine Venture Capital

HSMN NewsFeed - 31 Jan 2007
FDA Advisory Committee to Review DOR BioPharma's orBec(R) for the Treatment of GI GVHD
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jan 2007
Bayer Discontinues Trasylol(R) Clinical Trial Program in Non-CABG Indications
Biopharmaceuticals

HSMN NewsFeed - 25 Jan 2007
The New England Journal Of Medicine Publishes Two Landmark Studies Of NOXAFIL(R) (Posaconazole) in the Prevention of Invasive Fungal Infections
Biopharmaceuticals

HSMN NewsFeed - 15 Dec 2006
Bayer Pharmaceuticals Corporation Informs Health Care Professionals of Important Safety Revisions to the Trasylol Label
Biopharmaceuticals

HSMN NewsFeed - 28 Nov 2006
European Medicines Agency Accepts DOR BioPharma's MAA Filing for orBec(R)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Nov 2006
FDA Accepts DOR BioPharma's NDA Filing for orBec(R)
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 16 Nov 2006
CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial of PXD101 for Myelodysplastic Syndrome
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Nov 2006
Noxafil(R) (Posaconazole) Oral Suspension Approved in European Union for Prevention of Invasive Fungal Infections
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Nov 2006
DOR BioPharma Submits European Marketing Application for orBec(R) to Treat GI Graft-Versus-Host Disease
Biopharmaceuticals Regulatory

HSMN NewsFeed - 31 Oct 2006
Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Oct 2006
Bayer Appoints Independent Investigator to Review Trasylol(R) Study Issues
Biopharmaceuticals

HSMN NewsFeed - 10 Oct 2006
Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Sep 2006
Bayer Acknowledges That New Trasylol Study Was Not Disclosed Prior to Recent FDA Cardio-Renal Advisory Committee Meeting
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 29 Sep 2006
FDA Issues Approvable Letter to Ortec for Use of Cryopreserved OrCel(R) in Epidermolysis Bullosa Patients' Hand Reconstructions and Donor Sites
Regenerative Medicine FDA

HSMN NewsFeed - 28 Sep 2006
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
Biopharmaceuticals

HSMN NewsFeed - 27 Sep 2006
Gamida Cell Raises US$16 Million
Regenerative Medicine Venture Capital

HSMN NewsFeed - 27 Sep 2006
Pervasis Therapeutics' Vascugel(TM) Initiates U.S. Clinical Trials Following Successful FDA IND Review
Regenerative Medicine FDA

HSMN NewsFeed - 22 Sep 2006
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Sep 2006
European Union's CHMP Adopts Positive Opinion for NOXAFIL(R) (posaconazole) Oral Suspension for Prevention of Invasive Fungal Infections
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Sep 2006
FDA Advisory Committee Strongly Endorses Use of Trasylol(R) in CABG Surgery Patients
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 20 Sep 2006
Stem Cell Trials Show Sustained Heart Function Improvement
Regenerative Medicine Cardiology

HSMN NewsFeed - 18 Sep 2006
Schering-Plough Announces FDA Approval of NOXAFIL(R) (Posaconazole) for Prevention of Invasive Fungal Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Sep 2006
Ortec Announces Positive Results in Confirmatory Venous Leg Ulcer Trial
Devices Wound Care Regenerative Medicine

HSMN NewsFeed - 17 Jul 2006
Cambrex and Ortec Submit to FDA a Humanitarian Device Exemption (HDE) for OrCel(R) to Treat Epidermolysis Bullosa Patients
Devices

HSMN NewsFeed - 6 Jul 2006
Ortec Issues Update on Its Three Technology Platforms for Regenerative Medicine and Stem Cells
Regenerative Medicine

HSMN NewsFeed - 5 Jul 2006
Geron Presents New Data That Document Progress in Development of Therapeutic Products from Human Embryonic Stem Cells
Biopharmaceuticals Regenerative Medicine

Return to NewsFeed

Additional items found! 89

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 89 additional stories matching:
allogeneic
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!